We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
+$904M
Cap. Flow
+$84.9M
Cap. Flow %
0.49%
Top 10 Hldgs %
29.78%
Holding
722
New
36
Increased
329
Reduced
218
Closed
40

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$66.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.7M
3
AMZN icon
Amazon
AMZN
+$56.5M
4
AMD icon
Advanced Micro Devices
AMD
+$37.5M
5
CRM icon
Salesforce
CRM
+$35.5M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$122M
2
TMO icon
Thermo Fisher Scientific
TMO
+$60.8M
3
AMAT icon
Applied Materials
AMAT
+$43.7M
4
NU icon
Nu Holdings
NU
+$35.9M
5
INCY icon
Incyte
INCY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 31.8%
2 Healthcare 28.54%
3 Financials 9.44%
4 Consumer Discretionary 7.84%
5 Industrials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTRA icon
101
Natera
NTRA
$37B
$38.9M 0.22%
306,615
+106,608
+53% +$12.2M
KLAC icon
102
KLA
KLAC
$266B
$38.6M 0.22%
498,600
-103,710
-17% -$8.14M
ADBE icon
103
Adobe
ADBE
$94.5B
$38.1M 0.22%
73,497
+9,118
+14% +$5M
IONS icon
104
Ionis Pharmaceuticals
IONS
$9.25B
$38M 0.22%
948,266
– –
MDB icon
105
MongoDB
MDB
$24.9B
$37.9M 0.22%
140,052
+130
+0.1% +$33.8K
ABT icon
106
Abbott
ABT
$182B
$37.4M 0.21%
328,005
-31,671
-9% -$3.47M
CCK icon
107
Crown Holdings
CCK
$12.9B
$36.9M 0.21%
384,430
-33,507
-8% -$2.89M
XOM icon
108
ExxonMobil
XOM
$642B
$36.7M 0.21%
312,818
+10,077
+3% +$1.16M
BMA icon
109
Banco Macro
BMA
$5.89B
$36.2M 0.21%
570,700
-183,500
-24% -$10.6M
BBY icon
110
Best Buy
BBY
$18.6B
$35.8M 0.21%
346,875
+248,314
+252% +$22.4M
CNC icon
111
Centene
CNC
$31.6B
$35.7M 0.21%
474,874
-37,175
-7% -$2.72M
INSM icon
112
Insmed
INSM
$22.7B
$34.8M 0.2%
476,494
-79,440
-14% -$5.86M
NFLX icon
113
Netflix
NFLX
$293B
$34.7M 0.2%
488,740
-1,850
-0.4% -$124K
KO icon
114
Coca-Cola
KO
$362B
$34.4M 0.2%
478,623
+35,324
+8% +$2.42M
A icon
115
Agilent Technologies
A
$38.9B
$33.6M 0.19%
226,559
-17,914
-7% -$2.45M
HLT icon
116
Hilton Worldwide
HLT
$75.3B
$33.5M 0.19%
145,382
-96,669
-40% -$20.9M
PH icon
117
Parker-Hannifin
PH
$124B
$32.8M 0.19%
51,866
-18,324
-26% -$10.4M
NUVL
118
DELISTED
Nuvalent
NUVL
$32.6M 0.19%
318,367
+56,359
+22% +$4.67M
INTC icon
119
Intel
INTC
$462B
$31.9M 0.18%
1,360,668
+345,211
+34% +$8.62M
MPWR icon
120
Monolithic Power Systems
MPWR
$65.8B
$31.9M 0.18%
34,504
+32,085
+1,326% +$27.7M
MET icon
121
MetLife
MET
$61.2B
$31.4M 0.18%
380,549
+21,058
+6% +$1.57M
EXAS
122
DELISTED
Exact Sciences
EXAS
$31.1M 0.18%
456,591
+244,064
+115% +$13.8M
FTV icon
123
Fortive
FTV
$19.2B
$30M 0.17%
503,916
-25,569
-5% -$1.41M
SHW icon
124
Sherwin-Williams
SHW
$80.7B
$30M 0.17%
78,515
-34,975
-31% -$12.2M
FISV
125
Fiserv Inc
FISV
$27.9B
$30M 0.17%
166,732
+46,031
+38% +$7.59M
3 4
5
6 7

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2024 Portfolio in Review

As of Q3 2024, Candriam SCA held 722 positions worth $17.4B, up 5.5% from $16.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q3 2024 filing shows 36 new, 329 increased, 218 reduced and 40 closed positions. Its largest new stake was Avidity Biosciences: 323,396 shares worth $14.9M. The largest sale was Lam Research, an estimated $122M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2024 buy was Avidity Biosciences: 323,396 shares worth $14.9M.
  • Candriam SCA added most to Amgen in Q3 2024, an estimated $66.4M increase.
  • Candriam SCA's biggest Q3 2024 reduction was Thermo Fisher Scientific, cutting an estimated $60.8M.
  • Candriam SCA fully exited Lam Research in Q3 2024, selling an estimated $122M.
  • Candriam SCA's ten largest holdings make up 30% of its $17.4B portfolio in Q3 2024.
  • Candriam SCA opened 36 new positions and closed 40 in Q3 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q3 2024, filed 13 Nov 2024.